tiprankstipranks
Bristol-Myers Squibb Company (DE:BRM)
NYSE:BRM
Germany Market

Bristol-Myers Squibb (BRM) Technical Analysis

20 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Bristol-Myers Squibb Company’s (BRM) Moving Averages Convergence Divergence (MACD) indicator is 1.28, suggesting Bristol-Myers Squibb Company is a Sell.
Bristol-Myers Squibb Company’s (BRM) 20-Day exponential moving average is 51.48, while Bristol-Myers Squibb Company’s (BRM) share price is €50.86, making it a Buy.
Bristol-Myers Squibb Company’s (BRM) 50-Day exponential moving average is 50.12, while Bristol-Myers Squibb Company’s (BRM) share price is €50.86, making it a Buy.

Bristol-Myers Squibb (BRM) Pivot Points

Jul 24, 2026, 09:02 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
52.16
52.61
53.09
53.54
54.02
54.47
54.95
Fibonacci
52.61
52.97
53.19
53.54
53.90
54.12
54.47
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bristol-Myers Squibb (BRM) Moving Averages

Jul 24, 2026, 09:02 PM
Period
Simple
Exponential
MA5
53.59Buy
53.38Buy
MA10
52.37Buy
52.59Buy
MA20
51.21Buy
51.48Buy
MA50
49.50Buy
50.12Buy
MA100
49.56Buy
49.06Buy
MA200
46.51Buy
45.98Buy
Bristol-Myers Squibb Company’s (BRM) 10-Day exponential moving average is 52.59, while Bristol-Myers Squibb Company’s (BRM) share price is €50.86, making it a Buy.
Bristol-Myers Squibb Company’s (BRM) 100-Day exponential moving average is 49.06, while Bristol-Myers Squibb Company’s (BRM) share price is €50.86, making it a Buy.
Bristol-Myers Squibb Company’s (BRM) stock price is €50.86 and Bristol-Myers Squibb Company’s (BRM) 50-day simple moving average is 49.50, creating a Buy signal.
Bristol-Myers Squibb Company’s (BRM) stock price is €50.86 and Bristol-Myers Squibb Company’s (BRM) 100-day simple moving average is 49.56, creating a Buy signal.
Bristol-Myers Squibb Company’s (BRM) stock price is €50.86 and Bristol-Myers Squibb Company’s (BRM) 200-day simple moving average is 46.51, creating a Buy signal.

Bristol-Myers Squibb (BRM) Technical Indicators

Jul 24, 2026, 09:02 PM
Name
Value
Implied Action
RSI (14)
67.50
Neutral
STOCH (9,6)
81.88
Sell
STOCHRSI (14)
83.96
Sell
MACD (12,26)
1.28
Sell
ADX (14)
18.85
Buy
Williams %R
-2.51
Sell
CCI (14)
156.45
Sell
ATR (14)
1.22
-
Ultimate Oscillator
64.69
Neutral
ROC
8.35
Buy
Bristol-Myers Squibb Company’s (BRM) Relative Strength Index (RSI) is 67.50, creating a Neutral signal.
Bristol-Myers Squibb Company’s (BRM) Trend Strength Indicator (ADX) is 18.85, creating a Buy signal.
Bristol-Myers Squibb Company’s (BRM) Commodity Channel Index (CCI) is 156.45, creating a Sell signal.
Bristol-Myers Squibb Company’s (BRM) Price Rate of Change (ROC) is 8.35, creating a Buy signal.

FAQ

Is BRM a Buy, Hold, or Sell?
Based on BRM’s technical indicators, BRM is a Buy.
    What is BRM’s RSI (14)?
    BRM’s RSI (14) is 67.50, which suggests BRM is a Neutral.
      What is BRM’s MACD?
      BRM’s MACD is 1.28, which suggests BRM is a Sell.
        What is BRM’s 5-day moving average?
        BRM’s 5-day moving average is 53.59, which suggests BRM is a Buy.
          What is BRM’s 20-day moving average?
          BRM 20-day moving average is 51.21, which suggests BRM is a Buy.
            What is BRM’s 50-day moving average?
            BRM’s 50-day moving average is 49.50, which suggests BRM is a Buy.
              What is BRM’s 200-day moving average?
              BRM’s 200-day moving average is 46.51, which suggests BRM is a Buy.
                What is BRM’s Williams % R (14)?
                BRM’s Williams % R (14) is -2.51, which suggests BRM is a Sell.
                  What is BRM’s CCI (14)?
                  BRM’s CCI (14) is 156.45, which suggests BRM is a Sell.
                    What is the share price of Bristol-Myers Squibb Company?